Details for New Drug Application (NDA): 206384
✉ Email this page to a colleague
NDA 206384 describes RALOXIFENE HYDROCHLORIDE, which is a drug marketed by Amneal Pharms, Aurobindo Pharma, Cadila Pharms Ltd, Glenmark Pharms Ltd, Invagen Pharms, Sciegen Pharms Inc, Teva Pharms Usa, and Watson Labs Inc, and is included in eight NDAs. It is available from sixteen suppliers. Additional details are available on the RALOXIFENE HYDROCHLORIDE profile page.
The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.
Summary for 206384
| Tradename: | RALOXIFENE HYDROCHLORIDE |
| Applicant: | Sciegen Pharms Inc |
| Ingredient: | raloxifene hydrochloride |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 206384
| Mechanism of Action | Selective Estrogen Receptor Modulators |
Medical Subject Heading (MeSH) Categories for 206384
Suppliers and Packaging for NDA: 206384
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| RALOXIFENE HYDROCHLORIDE | raloxifene hydrochloride | TABLET;ORAL | 206384 | ANDA | Major Pharmaceuticals | 0904-6902 | 0904-6902-04 | 30 BLISTER PACK in 1 CARTON (0904-6902-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
| RALOXIFENE HYDROCHLORIDE | raloxifene hydrochloride | TABLET;ORAL | 206384 | ANDA | Dr.Reddy?s Laboratories Inc | 43598-505 | 43598-505-01 | 100 TABLET, FILM COATED in 1 BOTTLE (43598-505-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
| Approval Date: | Oct 12, 2016 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
